Skip to main content
. 2017 Sep 19;8(5):1123–1134. doi: 10.1007/s13300-017-0299-7

Fig. 1.

Fig. 1

Trial design and participant flow. a Schematic illustration of the trial design. b Participant flow. Data are presented as n. α-GI alpha-glucosidase inhibitor, Lab laboratory test, M month, OGTT 75-g oral glucose tolerance test